Weihe Zhang, Wei Wang, Jie Luo, Geng Qin, J. Jiao, Yu Wang, Yi Jin, Zhengyun Li, W. Gu
{"title":"The clinical, imaging, intestinal pathological characteristics of gluten ataxia: a case report in Chinese mainland","authors":"Weihe Zhang, Wei Wang, Jie Luo, Geng Qin, J. Jiao, Yu Wang, Yi Jin, Zhengyun Li, W. Gu","doi":"10.3760/CMA.J.ISSN.1006-7876.2019.02.006","DOIUrl":null,"url":null,"abstract":"Objective \nTo investigate the clinical, imaging, intestinal pathological characteristics and prognosis of gluten ataxia (GA). \n \n \nMethods \nThe clinical data, treatment and prognosis in a patient with GA that was confirmed by pathology and hospitalized in the Department of Neurology, China-Japan Friendship Hospital in July 2018, were analyzed retrospectively. The related literature was reviewed and the clinical feature was summarized. \n \n \nResults \nThe patient is a 41-year old man. He suffered from progressive cerebellar ataxia, and the brain magnetic resonance imaging exhibited diffused cerebellar atrophy. Serum human leukocyte antigen (HLA) tests showed that the patient carried HLA-DQ2 genotype. IgA type anti-gliadin antibody was positive (39.39 RU/ml). Duodenoscopy biopsy revealed mild villus atrophy and lymphocytic infiltration, indicating celiac disease. The diagnosis of GA was established then and the patient was administered gluten-free diet combined with intravenous immunoglobulin, which markedly improved the cerebellar symptoms and signs of cerebellar speech, walk capability and daily living activities. He could do long distance driving independently two months later. \n \n \nConclusions \nGA is one of immune-mediated reversible acquired cerebellar ataxia caused by gluten sensitivity. The genotype, serologic features, and clinical phenotype of GA in Chinese mainland population might be similar with those in European and American countries. \n \n \nKey words: \nCerebellar ataxia; Glutens; Celiac disease; Biopsy; Anti-gliadin antibodies","PeriodicalId":10143,"journal":{"name":"中华神经科杂志","volume":"6 1","pages":"110-115"},"PeriodicalIF":0.0000,"publicationDate":"2019-02-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"中华神经科杂志","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.3760/CMA.J.ISSN.1006-7876.2019.02.006","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0
Abstract
Objective
To investigate the clinical, imaging, intestinal pathological characteristics and prognosis of gluten ataxia (GA).
Methods
The clinical data, treatment and prognosis in a patient with GA that was confirmed by pathology and hospitalized in the Department of Neurology, China-Japan Friendship Hospital in July 2018, were analyzed retrospectively. The related literature was reviewed and the clinical feature was summarized.
Results
The patient is a 41-year old man. He suffered from progressive cerebellar ataxia, and the brain magnetic resonance imaging exhibited diffused cerebellar atrophy. Serum human leukocyte antigen (HLA) tests showed that the patient carried HLA-DQ2 genotype. IgA type anti-gliadin antibody was positive (39.39 RU/ml). Duodenoscopy biopsy revealed mild villus atrophy and lymphocytic infiltration, indicating celiac disease. The diagnosis of GA was established then and the patient was administered gluten-free diet combined with intravenous immunoglobulin, which markedly improved the cerebellar symptoms and signs of cerebellar speech, walk capability and daily living activities. He could do long distance driving independently two months later.
Conclusions
GA is one of immune-mediated reversible acquired cerebellar ataxia caused by gluten sensitivity. The genotype, serologic features, and clinical phenotype of GA in Chinese mainland population might be similar with those in European and American countries.
Key words:
Cerebellar ataxia; Glutens; Celiac disease; Biopsy; Anti-gliadin antibodies